legislationactive3 updates
HB 2103: Directs the State Board of Pharmacy to adopt rules to classify xylazine as a Schedule IV controlled substance.
Tracking HB 2103 through the Oregon Legislature.
Updates
Newest first · click to expandBill ActionJune 27, 2025HB 2103
House: In committee upon adjournment.
Bill ActionJanuary 17, 2025HB 2103
House: Referred to Behavioral Health and Health Care.
Bill ActionJanuary 13, 2025HB 2103